Found: 32
Select item for more details and to access through your institution.
Radiolabeling and in vitro / in vivo evaluation of N-(1-adamantyl)-8-methoxy-4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxamide as a PET probe for imaging cannabinoid type 2 receptor.
- Published in:
- Journal of Neurochemistry, 2013, v. 126, n. 5, p. 616, doi. 10.1111/jnc.12354
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of a New Acyclic Pyrimidine Derivative as a Probe for Imaging Herpes Simplex Virus Type 1 Thymidine Kinase Gene Expression.
- Published in:
- Molecules, 2013, v. 18, n. 7, p. 8535, doi. 10.3390/molecules18078535
- By:
- Publication type:
- Article
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging.
- Published in:
- Frontiers in Neuroscience, 2016, p. 1, doi. 10.3389/fnins.2016.00350
- By:
- Publication type:
- Article
Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1772, doi. 10.2967/jnumed.123.265433
- By:
- Publication type:
- Article
Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: a prospective translational exploratory study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262426
- By:
- Publication type:
- Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu- PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261982
- By:
- Publication type:
- Article
Correlation of <sup>68</sup>Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: a prospective translational exploratory study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262426
- By:
- Publication type:
- Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic castration-reSISTant Prostate Cancer (RESIST-PC): efficacy results of the UCLA cohort.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261982
- By:
- Publication type:
- Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177LuPSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261982
- By:
- Publication type:
- Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261982
- By:
- Publication type:
- Article
Prospective phase 2 trial o _PSMA-targeted molecular RadiothErapy with 177Lu-PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261982
- By:
- Publication type:
- Article
Prospective phase 2 trial of PSMA-targeted molecular RadiothErapy with 177Lu- PSMA-617 for metastatic Castration-reSISTant Prostate Cancer (RESIST-PC): Efficacy results of the UCLA cohort.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.261982
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA-11 NDA Approval: A Novel and Successful Academic Partnership.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 2, p. 149, doi. 10.2967/jnumed.120.260455
- By:
- Publication type:
- Article
Mechanisms of Resistance to Prostate-Specific Membrane Antigen-Targeted Radioligand Therapy in a Mouse Model of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.256263
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Impact of 68Ga-PSMA-11 PET on the Management of recurrent Prostate Cancer in a Prospective Single-Arm Clinical Trial.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.242180
- By:
- Publication type:
- Article
Radiation dosimetry and biodistribution of <sup>68</sup>Ga-FAPI-46 PET imaging in cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.236786
- By:
- Publication type:
- Article
Detection Threshold and Reproducibility of <sup>68</sup>Ga-PSMA11 PET/CT in a Mouse Model of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 9, p. 1392, doi. 10.2967/jnumed.118.207704
- By:
- Publication type:
- Article
Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 3, p. 434, doi. 10.2967/jnumed.117.202945
- By:
- Publication type:
- Article
Most of the Intended Management Changes After <sup>68</sup>Ga-DOTATATE PET/CT Are Implemented.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 11, p. 1793, doi. 10.2967/jnumed.117.192450
- By:
- Publication type:
- Article
Establishing <sup>177</sup>Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 11, p. 1786, doi. 10.2967/jnumed.117.193359
- By:
- Publication type:
- Article
Human Biodistribution and Radiation Dosimetry of <sup>18</sup>F-Clofarabine, a PET Probe Targeting the Deoxyribonucleoside Salvage Pathway.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 3, p. 374, doi. 10.2967/jnumed.116.182394
- By:
- Publication type:
- Article
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2.
- Published in:
- Journal of Neurochemistry, 2016, v. 138, n. 6, p. 874, doi. 10.1111/jnc.13716
- By:
- Publication type:
- Article
Synthesis and preclinical evaluation of an AlF radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2016, v. 43, n. 12, p. 2122, doi. 10.1007/s00259-016-3437-y
- By:
- Publication type:
- Article
Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer.
- Published in:
- EJNMMI Research, 2018, v. 8, n. 1, p. 1, doi. 10.1186/s13550-018-0451-z
- By:
- Publication type:
- Article
Transforming an Academic Radiochemistry Facility for Positron Emission Tomography Drug cGMP Compliance.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Comparison of PSMA-TO-1 and PSMA-617 labeled with gallium-68, lutetium-177 and actinium-225.
- Published in:
- EJNMMI Research, 2022, v. 12, n. 1, p. 1, doi. 10.1186/s13550-022-00935-6
- By:
- Publication type:
- Article
Synthesis and Preliminary Evaluation of a 2-Oxoquinoline Carboxylic Acid Derivative for PET Imaging the Cannabinoid Type 2 Receptor.
- Published in:
- Pharmaceuticals (14248247), 2014, v. 7, n. 3, p. 339, doi. 10.3390/ph7030339
- By:
- Publication type:
- Article